1. Home
  2. SDA vs TVRD Comparison

SDA vs TVRD Comparison

Compare SDA & TVRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SDA
  • TVRD
  • Stock Information
  • Founded
  • SDA 2007
  • TVRD 2017
  • Country
  • SDA China
  • TVRD United States
  • Employees
  • SDA N/A
  • TVRD N/A
  • Industry
  • SDA Blank Checks
  • TVRD Biotechnology: Pharmaceutical Preparations
  • Sector
  • SDA Finance
  • TVRD Health Care
  • Exchange
  • SDA Nasdaq
  • TVRD Nasdaq
  • Market Cap
  • SDA 293.6M
  • TVRD 246.5M
  • IPO Year
  • SDA N/A
  • TVRD N/A
  • Fundamental
  • Price
  • SDA $2.59
  • TVRD $25.77
  • Analyst Decision
  • SDA Buy
  • TVRD Strong Buy
  • Analyst Count
  • SDA 1
  • TVRD 3
  • Target Price
  • SDA $3.50
  • TVRD $60.67
  • AVG Volume (30 Days)
  • SDA 71.3K
  • TVRD 76.5K
  • Earning Date
  • SDA 05-19-2025
  • TVRD 05-13-2025
  • Dividend Yield
  • SDA N/A
  • TVRD N/A
  • EPS Growth
  • SDA N/A
  • TVRD N/A
  • EPS
  • SDA N/A
  • TVRD N/A
  • Revenue
  • SDA $458,905,000.00
  • TVRD N/A
  • Revenue This Year
  • SDA $27.85
  • TVRD N/A
  • Revenue Next Year
  • SDA $14.55
  • TVRD N/A
  • P/E Ratio
  • SDA N/A
  • TVRD N/A
  • Revenue Growth
  • SDA 24.15
  • TVRD N/A
  • 52 Week Low
  • SDA $2.41
  • TVRD $8.13
  • 52 Week High
  • SDA $11.74
  • TVRD $34.31
  • Technical
  • Relative Strength Index (RSI)
  • SDA 41.55
  • TVRD N/A
  • Support Level
  • SDA $2.51
  • TVRD N/A
  • Resistance Level
  • SDA $3.08
  • TVRD N/A
  • Average True Range (ATR)
  • SDA 0.19
  • TVRD 0.00
  • MACD
  • SDA 0.00
  • TVRD 0.00
  • Stochastic Oscillator
  • SDA 23.68
  • TVRD 0.00

About SDA SunCar Technology Group Inc.

SunCar Technology Group Inc operates digital automotive aftersales market service platform and vehicle insurance technology platform. It develops and operates online platforms that connect drivers in China with a range of aftermarket automotive services and insurance coverage options from a nationwide network of service providers. These comprehensive digital systems are built on SunCar's multi-tenant, cloud-based platform.

About TVRD Tvardi Therapeutics Inc. Common Stock

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.

Share on Social Networks: